2m 2m 2m 2m 2m 2m 2m
MONOPAR THERAPE (MNPR)
NASDAQ
$107.77+$0.05 (+0.05%)
Price as of Aug 21, 2026 7:30 PM EDT- $723.0MMarket Cap
- 236.00%1-Year Change
- BiotechnologyIndustry
MONOPAR THERAPE (MNPR)
$107.77+$0.05 (+0.05%)
MNPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $107.72 | ||
Change | -$3.16 (-2.85%) | ||
Open | $111.98 | ||
High | $113.46 | ||
Low | $105.42 | ||
Previous Close | $110.88 | ||
Volume | 176,420 | ||
30-Day Average Volume | 287,879 | ||
1-Week Change | -4.71% | ||
1-Month Change | -5.15% | ||
1-Year Change | 236.00% | ||
3-Year Change | 3,220.59% | ||
5-Year Change | 359.37% | ||
Fundamentals | |||
Shares Outstanding | 6.7M | ||
Total Assets | $135.0M | ||
Market Cap | $723.0M | ||
Enterprise Value | $670.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $130.7M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -126 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -174 | ||
PEG | 5 | ||
Price/Free Cash Flow | -223 | ||
Price/Operating Cash Flow | -223 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 08/13/2024 | ||
Earnings & Revenue